BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 2132926)

  • 1. Prognostic factors in childhood ependymomas.
    Sutton LN; Goldwein J; Perilongo G; Lang B; Schut L; Rorke L; Packer R
    Pediatr Neurosurg; 1990-1991; 16(2):57-65. PubMed ID: 2132926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group.
    Robertson PL; Zeltzer PM; Boyett JM; Rorke LB; Allen JC; Geyer JR; Stanley P; Li H; Albright AL; McGuire-Cullen P; Finlay JL; Stevens KR; Milstein JM; Packer RJ; Wisoff J
    J Neurosurg; 1998 Apr; 88(4):695-703. PubMed ID: 9525716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy.
    Packer RJ; Sutton LN; Elterman R; Lange B; Goldwein J; Nicholson HS; Mulne L; Boyett J; D'Angio G; Wechsler-Jentzsch K
    J Neurosurg; 1994 Nov; 81(5):690-8. PubMed ID: 7931615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant chemotherapy for the treatment of intracranial ependymoma of childhood.
    Needle MN; Goldwein JW; Grass J; Cnaan A; Bergman I; Molloy P; Sutton L; Zhao H; Garvin JH; Phillips PC
    Cancer; 1997 Jul; 80(2):341-7. PubMed ID: 9217048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant chemotherapy of childhood posterior fossa ependymoma: cranio-spinal irradiation with or without adjuvant CCNU, vincristine, and prednisone: a Childrens Cancer Group study.
    Evans AE; Anderson JR; Lefkowitz-Boudreaux IB; Finlay JL
    Med Pediatr Oncol; 1996 Jul; 27(1):8-14. PubMed ID: 8614396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: a report from the Childrens Cancer Group.
    Geyer JR; Zeltzer PM; Boyett JM; Rorke LB; Stanley P; Albright AL; Wisoff JH; Milstein JM; Allen JC; Finlay JL
    J Clin Oncol; 1994 Aug; 12(8):1607-15. PubMed ID: 8040673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracranial ependymomas: treatment results and prognostic factors.
    Zorlu AF; Atahan IL; Akyol FH; Gürkaynak M; Ozyar E
    Radiat Med; 1994; 12(6):269-72. PubMed ID: 7724818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French Society of Pediatric Oncology.
    Grill J; Le Deley MC; Gambarelli D; Raquin MA; Couanet D; Pierre-Kahn A; Habrand JL; Doz F; Frappaz D; Gentet JC; Edan C; Chastagner P; Kalifa C;
    J Clin Oncol; 2001 Mar; 19(5):1288-96. PubMed ID: 11230470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors.
    Duffner PK; Horowitz ME; Krischer JP; Friedman HS; Burger PC; Cohen ME; Sanford RA; Mulhern RK; James HE; Freeman CR
    N Engl J Med; 1993 Jun; 328(24):1725-31. PubMed ID: 8388548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group.
    Finlay JL; Boyett JM; Yates AJ; Wisoff JH; Milstein JM; Geyer JR; Bertolone SJ; McGuire P; Cherlow JM; Tefft M
    J Clin Oncol; 1995 Jan; 13(1):112-23. PubMed ID: 7799011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary postoperative chemotherapy without radiotherapy for intracranial ependymoma in children: the UKCCSG/SIOP prospective study.
    Grundy RG; Wilne SA; Weston CL; Robinson K; Lashford LS; Ironside J; Cox T; Chong WK; Campbell RH; Bailey CC; Gattamaneni R; Picton S; Thorpe N; Mallucci C; English MW; Punt JA; Walker DA; Ellison DW; Machin D;
    Lancet Oncol; 2007 Aug; 8(8):696-705. PubMed ID: 17644039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic significance of postoperative residual tumor in ependymoma.
    Healey EA; Barnes PD; Kupsky WJ; Scott RM; Sallan SE; Black PM; Tarbell NJ
    Neurosurgery; 1991 May; 28(5):666-71; discussion 671-2. PubMed ID: 1876244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative radiotherapy in the management of spinal cord ependymoma.
    Whitaker SJ; Bessell EM; Ashley SE; Bloom HJ; Bell BA; Brada M
    J Neurosurg; 1991 May; 74(5):720-8. PubMed ID: 2013772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative chemotherapy without radiation in young children with malignant non-astrocytic brain tumours. A report from the Australia and New Zealand Childhood Cancer Study Group (ANZCCSG).
    White L; Johnston H; Jones R; Mameghan H; Nayanar V; McWhirter W; Kellie S; Waters K; Toogood I
    Cancer Chemother Pharmacol; 1993; 32(5):403-6. PubMed ID: 8339393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of 6-thioguanine, procarbazine, dibromodulcitol, lomustine, and vincristine chemotherapy with radiotherapy for treating malignant glioma in children.
    Levin VA; Lamborn K; Wara W; Davis R; Edwards M; Rabbitt J; Malec M; Prados MD
    Neuro Oncol; 2000 Jan; 2(1):22-8. PubMed ID: 11302250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of intracranial ependymomas of children: review of a 15-year experience.
    Rousseau P; Habrand JL; Sarrazin D; Kalifa C; Terrier-Lacombe MJ; Rekacewicz C; Rey A
    Int J Radiat Oncol Biol Phys; 1994 Jan; 28(2):381-6. PubMed ID: 8276653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracranial ependymomas: analysis of prognostic factors in a population-based series.
    Foreman NK; Love S; Thorne R
    Pediatr Neurosurg; 1996; 24(3):119-25. PubMed ID: 8870014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review of treatment outcomes in pediatric patients with intracranial ependymomas.
    Cage TA; Clark AJ; Aranda D; Gupta N; Sun PP; Parsa AT; Auguste KI
    J Neurosurg Pediatr; 2013 Jun; 11(6):673-81. PubMed ID: 23540528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.
    Thorarinsdottir HK; Rood B; Kamani N; Lafond D; Perez-Albuerne E; Loechelt B; Packer RJ; MacDonald TJ
    Pediatr Blood Cancer; 2007 Mar; 48(3):278-84. PubMed ID: 16456857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ependymal tumors in childhood.
    Agaoglu FY; Ayan I; Dizdar Y; Kebudi R; Gorgun O; Darendeliler E
    Pediatr Blood Cancer; 2005 Sep; 45(3):298-303. PubMed ID: 15770637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.